CA2151234A1 - Dosage des liens pyridinium dans le serum - Google Patents

Dosage des liens pyridinium dans le serum

Info

Publication number
CA2151234A1
CA2151234A1 CA 2151234 CA2151234A CA2151234A1 CA 2151234 A1 CA2151234 A1 CA 2151234A1 CA 2151234 CA2151234 CA 2151234 CA 2151234 A CA2151234 A CA 2151234A CA 2151234 A1 CA2151234 A1 CA 2151234A1
Authority
CA
Canada
Prior art keywords
antibody
pyd
crosslinks
dpd
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2151234
Other languages
English (en)
Inventor
Viola T. Kung
Baltazar Gomez Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metra Biosystems Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2151234A1 publication Critical patent/CA2151234A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C19/00—Dental auxiliary appliances
    • A61C19/06—Implements for therapeutic treatment
    • A61C19/063—Medicament applicators for teeth or gums, e.g. treatment with fluorides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA 2151234 1992-12-17 1993-12-17 Dosage des liens pyridinium dans le serum Abandoned CA2151234A1 (fr)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US99293692A 1992-12-17 1992-12-17
US99288892A 1992-12-17 1992-12-17
US07/992,888 1992-12-17
US07/992,936 1992-12-17
US3760293A 1993-03-26 1993-03-26
US08/037,602 1993-03-26
US14028493A 1993-10-20 1993-10-20
US08/140,284 1993-10-20

Publications (1)

Publication Number Publication Date
CA2151234A1 true CA2151234A1 (fr) 1994-06-23

Family

ID=27488456

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2151234 Abandoned CA2151234A1 (fr) 1992-12-17 1993-12-17 Dosage des liens pyridinium dans le serum

Country Status (4)

Country Link
JP (1) JP3448295B2 (fr)
AU (1) AU5851494A (fr)
CA (1) CA2151234A1 (fr)
WO (1) WO1994014072A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756361A (en) * 1992-12-17 1998-05-26 Metra Biosystems, Inc. Screening method for periodontal disease
US5661039A (en) * 1995-03-01 1997-08-26 Metra Biosystems, Inc. Perspiration assay for bone resorption
ATE258310T1 (de) * 1997-07-31 2004-02-15 Metra Biosystems Inc Testverfahren für collagenpeptid
WO2000040974A1 (fr) * 1999-01-07 2000-07-13 Quidel Corporation Dosage de liaisons reticulees de pyridinium

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300434A (en) * 1987-11-06 1994-04-05 Washington Research Foundation Hybridoma cell line producing an antibody to type-I collagen amino-terminal telopeptide

Also Published As

Publication number Publication date
JPH08507140A (ja) 1996-07-30
JP3448295B2 (ja) 2003-09-22
AU5851494A (en) 1994-07-04
WO1994014072A1 (fr) 1994-06-23

Similar Documents

Publication Publication Date Title
US6210902B1 (en) Estimation of the fragmentation pattern of collagen in body fluids and the diagnosis of disorders associated with the metabolism of collagen
US20060073536A1 (en) Immunoassays for determining vitamin B12, and reagents and kits therefor
US5700693A (en) Method to detect bone and other connective tissue disorders in humans and animals
US5374533A (en) Method for determining chondrocalcin
EP0787301B1 (fr) Evaluation du schema de fragmentation du collagene dans des fluides corporels et diagnostic des troubles associes au metabolisme du collagene
US5620861A (en) Method and kit for pyridinium crosslink assay
US5527715A (en) Method and kit for pyridinoline assay
US5736344A (en) Serum pyridinium crosslinks assay
CA2007338A1 (fr) Dosage de la vitamine b12
EP0653067B1 (fr) Procede et materiel de reticulation en presence d'ions pyridium
US5661039A (en) Perspiration assay for bone resorption
CA2151234A1 (fr) Dosage des liens pyridinium dans le serum
JPH08100000A (ja) ヒトｉｖ型コラーゲンに対する抗体及びその利用
US6107047A (en) Assaying protein fragments in body fluids
US5973123A (en) Immunoassay for the detection of MIA
US5437981A (en) Method for the immunological determination of ligands
CA1243944A (fr) Reactif et procede pour le dosage quantitatif des anticorps
EP1232396B1 (fr) Dosage de proteines et fragments de proteines isomerisees et/ou optiquement inversees
CA2110019C (fr) Immunodetection de la vitamine b12, reactifs et trousses
EP0425665B1 (fr) Procede d'analyse de chondrocalcine
CA2034922A1 (fr) Methode de determination immunologique des ligands
EP1485718A2 (fr) Procede de controle de la degradation du collagene de type ii dans le cartilage
KR100460292B1 (ko) 체액중의단백질파편검정
JPH10123132A (ja) アガラクトＩｇＧの測定法および測定キット
WO1994006015A1 (fr) Procede de surveillance de therapie medicamenteuse et d'evaluation de metastase

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead